Literature DB >> 6263984

Specific cellular and humoral immunity after immunization with live Towne strain cytomegalovirus vaccine.

S E Starr, J P Glazer, H M Friedman, J D Farquhar, S A Plotkin.   

Abstract

Cytomegalovirus-specific lymphocyte proliferation and immunofluorescent antibody responses were measured serially in five normal adults and eight candidates for renal transplant immunized with Towne strain cytomegalovirus vaccine. All of the normal adults developed cellular and humoral immune responses. Five of the eight immunized renal transplant candidates developed proliferative responses comparable to those of normal adults, although in two instances maximal responses were delayed. Vaccinees developed proliferative responses to antigens prepared from the Towne strain as well as heterologous strains of cytomegalovirus. The appearance of immunofluorescent antibodies was generally delayed for the renal transplant candidates, and two of the individuals who had poor proliferative responses also had low antibody titers.

Mesh:

Substances:

Year:  1981        PMID: 6263984     DOI: 10.1093/infdis/143.4.585

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Cytomegalovirus Vaccines: Current Status and Future Prospects.

Authors:  K M Anderholm; C J Bierle; M R Schleiss
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

2.  Cytomegalovirus infection in heart transplant recipients: preliminary results of a controlled trial of intravenous gamma globulin.

Authors:  J K Preiksaitis; S Rosno; L Rasmussen; T C Merigan
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

3.  Viral vaccines: the use of currently available products and future developments.

Authors:  E Norrby
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 4.  Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Authors:  Mark R Schleiss; Sallie R Permar; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

5.  Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression.

Authors:  S Pepperl; J Münster; M Mach; J R Harris; B Plachter
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 6.  The history of vaccination against cytomegalovirus.

Authors:  Stanley Plotkin
Journal:  Med Microbiol Immunol       Date:  2015-03-20       Impact factor: 3.402

Review 7.  Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment.

Authors:  Kristy M Bialas; Geeta K Swamy; Sallie R Permar
Journal:  Clin Perinatol       Date:  2014-11-28       Impact factor: 3.430

Review 8.  Prevention of cytomegalovirus infection in the pediatric renal transplant recipient.

Authors:  P L Hibberd; R H Rubin
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 9.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys.

Authors:  Cody S Nelson; Diana Vera Cruz; Dollnovan Tran; Kristy M Bialas; Lisa Stamper; Huali Wu; Margaret Gilbert; Robert Blair; Xavier Alvarez; Hannah Itell; Meng Chen; Ashlesha Deshpande; Flavia Chiuppesi; Felix Wussow; Don J Diamond; Nathan Vandergrift; Mark R Walter; Peter A Barry; Michael Cohen-Wolkowiez; Katia Koelle; Amitinder Kaur; Sallie R Permar
Journal:  JCI Insight       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.